501 results on '"Funck-Brentano C"'
Search Results
2. Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600mut melanoma patients
3. Comment éviter les revues prédatrices ?
4. Clinical pharmacology of anti-angiogenic drugs in oncology
5. Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin
6. Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes
7. Influence of multidrug resistance p-glycoprotein gene polymorphism or inhbition on plasma aldosterone concentration in healthy subjects: 2.11
8. Reply to the letter to the editor ‘Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumor response and tolerance’ by Funck-Brentano et al.
9. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
10. Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance†
11. Influence of ABCB1 genotype and of a P-gp drug inhibitor, clarithromycin, on dabigatran and rivaroxaban pharmacokinetic profiles in healthy volunteers: OR196
12. 2019 ESC Guide on the Diagnosis and Treatment of Chronic Coronary Syndromes
13. Genetic and environmental risk factors for oral anticoagulant overdose
14. Is diclofenac a valuable CYP2C9 probe in humans?
15. Tolérance cardiaque de la moxifloxacine : expérience clinique issue d'une large étude observationnelle française en pratique médicale usuelle (étude IMMEDIAT)
16. Effects of oxytocin on Purkinje fibres
17. Effects of HIV Protease Inhibitors on Cardiac Conduction Velocity in Unselected HIV-Infected Patients
18. P.006 Cardiac safety of esketamine nasal spray in treatment-resistant depression: Results from the clinical development program
19. P2597Heart failure and atrial tachyarrhythmia on abiraterone: a characterization using pharmacovigilance databases
20. P6590Androgenic effects on ventricular repolarization: a translational study from pharmacovigilance databases to iPSC-cardiomyocytes
21. P1591Cardiovascular toxicity of ibrutinib: a pharmacovigilance study
22. Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects
23. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
24. Amiodarone Interacts with Simvastatin but not with Pravastatin Disposition Kinetics
25. Adaptation of the Clinical Trials Directive
26. Transposition de la Directive Essais Cliniques
27. Third universal definition of myocardial infarction
28. Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers
29. Pharmacogénétique, étude du génome et développement des médicaments
30. Pharmacogenetic and Pharmacogenomic Studies
31. BETA-RECEPTOR OCCUPANCY AFTER CHRONIC BISOPROLOL DOSING
32. Relation entre concentrations plasmatiques de dabrafénib (D) et tramétinib (T), contrôle du mélanome avancé, et effets indésirables (EI)
33. Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers
34. ESC/ERS 2015 guidelines for the diagnosis and treatment of pulmonary hypertension
35. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
36. Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
37. L’hypogonadisme peut être un facteur de risque de torsade de pointes chez l’homme
38. Allongement du QTc et risque de torsades de pointe sous modulateurs sélectifs des récepteurs aux estrogènes versus anti-aromatase : une étude de disproportionnalité dans la base de pharmacovigilance européenne (SERENA)
39. Complex influence of endocrine and neuro-vegetative disorders on ventricular repolarization in diabetic patients
40. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
41. Erratum: 'European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)' the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
42. Évaluation de la fonction ventriculaire gauche chez des patients atteints d’hyperplasie congénitale des surrénales
43. Genome wide analysis of sotalol-induced IKr inhibition during ventricular repolarization, “GENEREPOL study”: lack of common variants with large effect sizes
44. Inappropriate intensity statin therapy causing worse lipid profiles in HIV-infected individuals after acute coronary syndrome
45. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
46. 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation [Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012]
47. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
48. Guidelines for the diagnosis and treatment of pulmonary hypertension Orientações para o diagnóstico e tratamento da hipertensão pulmonar
49. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
50. Myocardial revascularization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.